M&N’s CBD is a biotech startup engaged in the research and commercialization of new materials. To date, they have planned and developed over 200 CBD products and have succeeded, for the first time in the industry, in researching nano CBD formulations that dramatically enhance the absorption efficiency of CBD. In May 2022, they raised approximately 150 million JPY in Series A funding. Their CBD products are already distributed to over 500 stores nationwide, including medical institutions.

FACT BOX

  • Source: PR TIMES
  • Category: Event
  • Organizations: M&N’s CBD